Article
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases.
Clinical epigenetics - 1 Jan 2017
Cohen Stacey A, Yu Ming, Baker Kelsey, Redman Mary, Wu Chen, Heinzerling Tai J, Wirtz Ralph M, Charalambous Elpida, Pentheroudakis George, Kotoula Vassiliki, Kalogeras Konstantine T, Fountzilas George, Grady William M
Abstract excerpt
BACKGROUND: The CpG island methylator phenotype (CIMP) in stage III colon cancer (CRC) has been associated with improved survival after treatment with adjuvant irinotecan-based chemotherapy. In this analysis, we determine whether CIMP status in the primary CRC is concordant with the CIMP status of matched metastases in order to determine if assessment of CIMP status in the primary tumor can be used to predict...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
